Hb Fuller (FUL) valuation
Hb Fuller P/E ratio history
Hb Fuller trades at 13.9 times its earnings over the last twelve months and 9.8 times the earnings analysts expect over the next twelve. At its last 10 fiscal year ends its P/E ranged from 14.7 (year to Dec 2018) to 48.4 (year to Dec 2017), with a median of 23.7.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Nov 29, 2025 | $58.28 | $2.75 | 21.2 | 13.0 |
| Nov 30, 2024 | $76.89 | $2.30 | 33.4 | 17.0 |
| Dec 2, 2023 | $76.89 | $2.59 | 29.7 | — |
| Dec 3, 2022 | $80.33 | $3.26 | 24.6 | — |
| Nov 27, 2021 | $73.90 | $2.97 | 24.9 | 18.5 |
| Nov 28, 2020 | $53.73 | $2.36 | 22.8 | — |
| Nov 30, 2019 | $49.88 | $2.52 | 19.8 | — |
| Dec 1, 2018 | $48.24 | $3.29 | 14.7 | — |
| Dec 2, 2017 | $55.65 | $1.15 | 48.4 | — |
| Dec 3, 2016 | $46.44 | $2.37 | 19.6 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Hb Fuller valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Hb FullerFUL | $2.67B | 13.9 | 9.8 | 0.8 |
| Ardagh Metal Packaging SaAMBP | $2.69B | 56.3 | 15.9 | 0.4 |
| Quaker HoughtonKWR | $2.60B | 27.1 | 16.5 | 1.3 |
| IngevityNGVT | $2.58B | 49.2 | 13.2 | 2.2 |
| InnospecIOSP | $2.46B | 20.4 | 18.0 | 1.3 |
| Constellium SeCSTM | $3.13B | 5.7 | 7.6 | 0.3 |
| HawkinsHWKN | $3.18B | 37.0 | 34.6 | 2.8 |
| United States Lime And Minerals InUSLM | $3.20B | 23.9 | 20.8 | 8.5 |
| Knife RiverKNF | $3.26B | 23.5 | 20.7 | 1.0 |
| Peer median | 25.5 | 17.3 | 1.3 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: FUL financials · FUL returns
No forecast, no recommendation. This page describes Hb Fuller from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.